Cargando…
High ALDH1 Expression Correlates with Better Prognosis in Tumorigenic Malignant Melanoma
Aldehyde dehydrogenase 1 (ALDH1) has been proposed as biomarker of stem cells for certain human cancers. ALDH1 expression has been correlated with poor patient outcomes in a variety of malignancies but better patient outcomes in others, and its prognostic significance in malignant melanoma is unclea...
Autores principales: | Taylor, Laura A., Abraham, Ronnie M., Tahirovic, Emin, van Belle, Patricia, Li, Bin, Huang, Linfang, Elder, David E., Gimotty, Phyllis, Xu, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584688/ https://www.ncbi.nlm.nih.gov/pubmed/28106104 http://dx.doi.org/10.1038/modpathol.2016.226 |
Ejemplares similares
-
ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH(High) Melanoma-Initiating Cells
por: Sarvi, Sana, et al.
Publicado: (2018) -
Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma
por: Prasmickaite, Lina, et al.
Publicado: (2010) -
ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers
por: Chang, Bin, et al.
Publicado: (2009) -
ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
por: Adams, April, et al.
Publicado: (2015) -
PD-L1 Promotes Self-Renewal and Tumorigenicity of Malignant Melanoma Initiating Cells
por: Zheng, Fang, et al.
Publicado: (2017)